HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,029-2,040 of 4,505
Other study type icon
CompletedNCT01959659

A Non-Interventional Study of people with Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness

What is this study about?

This completed observational study examined healthcare use and the impact of persistent schizophrenia symptoms despite adequately dosed antipsychotic treatment.

This study has finished and is no longer accepting participants.

Multiple locations, including Epping
SchizophreniaObservational studyAges 18+
Countries
Australia, France, Czechia, + 4 others
Sponsor
Hoffmann-La Roche
Drug study icon
CompletedNCT01606254

Safety study of paliperidone Palmitate in schizophrenia

Official study title

A Repeated Dose Study of JNS010 (Paliperidone Palmitate) in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Ichikawa
SchizophreniaMedication studyAges 20–65
Countries
Japan
Sponsor
Janssen Pharmaceutical K.K.
Drug study icon
CompletedNCT01812642

Safety study of JNJ-37822681 in schizophrenia

What is this study about?

This study evaluated the safety of JNJ-37822681 for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Antwerp
SchizophreniaMedication studyAges 20–55
Countries
Belgium, Germany, Russia, + 2 others
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug study icon
CompletedNCT02804568

Safety Study in Adults With Schizophrenia

What is this study about?

This study evaluated the safety of ALKS 3831 for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–55
Countries
United States
Sponsor
Alkermes, Inc.
Drug study icon
CompletedNCT02477020

TAK-063 for schizophrenia

What is this study about?

Researchers compared TAK-063 20 mg and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Springdale
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
Takeda
Drug study icon
CompletedNCT01678755

ABT-126 for schizophrenia

What is this study about?

Researchers compared ABT-126 and placebo to find out how the approaches affected memory, attention and other thinking skills in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Chino
SchizophreniaMedication studyAges 20–55
Countries
United States
Sponsor
AbbVie (prior sponsor, Abbott)
Drug study icon
CompletedNCT02873208

Safety study of ALKS 3831 in schizophrenia

What is this study about?

Researchers studied ALKS 3831, tracking side effects to assess long-term safety and tolerability in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–55
Countries
United States
Sponsor
Alkermes, Inc.
Drug study icon
CompletedNCT00915512

Response to Treatment and Safety of Paliperidone Extended-Release for schizophrenia

Official study title

An Open-label, Single-arm, Multicenter, Phase IV Study to Evaluate the Response to Treatment and Safety of Flexible Dose Treatment With Extended-release Paliperidone in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Adana
SchizophreniaMedication studyAges 18–65
Countries
Türkiye
Sponsor
Janssen-Cilag Turkey
Other study type icon
CompletedNCT01015001

A Sham-controlled study of Repetitive Transcranial Magnetic Stimulation for people with Refractory Schizophrenia Treated With Clozapine

Official study title

A Pilot Double-blind Sham-controlled Trial of Repetitive Transcranial Magnetic Stimulation for Patients With Refractory Schizophrenia Treated With Clozapine

This study has finished and is no longer accepting participants.

In Porto Alegre
SchizophreniaPlacebo comparisonAges 18–65
Countries
Brazil
Sponsor
Hospital de Clinicas de Porto Alegre
Drug study icon
CompletedNCT07671040

A Study of Adjunctive Structured Supportive Psychotherapy in Schizophrenia

Official study title

Effects of Adjunctive Structured Supportive Psychotherapy on Cognitive Function and Serum High-Sensitivity C-Reactive Protein in Schizophrenia: A Pilot Randomized Controlled Trial

This study has finished and is no longer accepting participants.

In Makassar
SchizophreniaMedication studyAges 20–45
Countries
Indonesia
Sponsor
Hasanuddin University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.